Dr Reddys Laboratories Ltd Share Price Today - Live Blog for May 12, 2026

The stock of Dr Reddys Laboratories Ltd is facing a -0.84% decline and is currently trading at 1269.10 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd's share price has dropped by -0.38%, a development that warrants careful analysis. Presently trading at 1275.10, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd stock price decreased by -0.38%, with the current market value at 1275.10 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd share price surged by 0.01%. With its current market price standing at 1280.00 per share, this stock is garnering increased attention from the investment community.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.01% increase and currently trading at 1280.00 per share. This upward trajectory is turning heads in the market.

With a -0.05% decrease, Dr Reddys Laboratories Ltd's share price is now 1279.20. Investors should examine the factors driving this decline. The stock's PE ratio is 19.3400, whereas the industry PE ratio stands at 34.4177.

Dr Reddys Laboratories Ltd shares saw a -0.05% decrease, reaching a current market price of 1279.20. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 19.3400, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd share price surged by 0.32%. With its current market price standing at 1284.00 per share, this stock is garnering increased attention from the investment community.

Dr Reddys Laboratories Ltd experienced a substantial 0.32% boost in its share price and has garnered significant attention from the market. It's now trading at 1284.00, making it an appealing option for investors.

Dr Reddys Laboratories Ltd share price has declined by -0.51%, and it's currently trading at 1273.40. The stock maintains a PE of 19.3400, while the industry PE is 34.4177, prompting discussions about its valuation.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.51% in its share price, and it currently trades at 1273.40 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.